Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000096

Chief Executive Officer sold 2,452 shares at $95.71 ($234,681)

From the SEC's structured data for this filing

Trades in this filing

Klein Lawrence Otto · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-09-15 Sale : show line 1 in the form −2,452 $95.71 $234,681 923,128 D
Open-market sales · 2,452 sh · avg $95.71 · $234,681
Loading xslF345X06/form4.xml…